Liquidia Corp. (LQDA)
36.60
+0.74
(+2.06%)
USD |
NASDAQ |
Jan 12, 16:00
36.90
+0.30
(+0.82%)
After-Hours: 20:00
Liquidia Research and Development Expense (Quarterly): 9.07M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp. | 98.30M |
| Integer Holdings Corp. | 10.95M |
| Armata Pharmaceuticals, Inc. | 5.824M |
| Merck & Co., Inc. | 3.552B |
| AIM ImmunoTech, Inc. | 0.525M |